Literature DB >> 16172143

Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata.

Jian-Jun Wei1, Luis Chiriboga, Alan A Arslan, Jonathan Melamed, Herman Yee, Khush Mittal.   

Abstract

BACKGROUND: Black ethnicity is one of the risk factors for uterine leiomyomata (ULM). Little is known about the ethnic differences in leiomyoma-associated gene products in women with uterine leiomyomata.
METHODS: A total of 120 hysterectomies with ULM were collected from black, Asian, Hispanic and white women (30 cases from each group). Twenty-two gene products were selected for the study. The expressions of the selected dysregulated gene products were measured by the semiquantification and the immunoscores were normalized by matched myometrium.
RESULTS: The relative expressions of progesterone receptor A (PR-A) (up-regulation), retinoid acid receptor alpha (down-regulation), and retinoid X receptor alpha (RXRalpha) (no change) in leiomyomata compared to normal myometrium in black women were significantly different compared to other ethnic groups (P < 0.05). About one-third of ULM from black women subclustered together in association with a group of up-regulated gene products. Many other gene products, including local growth factors, insulin-like growth factor (IGF)-signalling proteins, and cell proliferation markers, were dysregulated in ULM but showed non-significant differences between the ethnic groups.
CONCLUSIONS: There are substantial differences of the sex steroid receptors and other nuclear receptors between black women and other ethnic groups. Based on tissue microarray data, there are at least two broad groups of leiomyomata presented by the dysregulation of different groups of gene products. One is dominated by up-regulation of amplified in breast cancer 1, CD24, hamartin, human mobility group gene 2, IGF2, PR-A and RXR, and the other is characterized by up-regulation of epithelial growth factor receptor, down-regulation of hamartin, PR-A and tuberin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172143     DOI: 10.1093/humrep/dei309

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.

Authors:  Karen L Huyck; Carolien I M Panhuysen; Karen T Cuenco; Jingmei Zhang; Hilary Goldhammer; Emlyn S Jones; Priya Somasundaram; Allison M Lynch; Bernard L Harlow; Hang Lee; Elizabeth A Stewart; Cynthia C Morton
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

2.  Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.

Authors:  Jia Xie; Julianne Ubango; Yanli Ban; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2018-08-20       Impact factor: 5.006

Review 3.  Molecular genetics and racial disparities of uterine leiomyomas.

Authors:  Essam-Eldin R Othman; Ayman Al-Hendy
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2008-03-25       Impact factor: 5.237

4.  A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function.

Authors:  J Brandon Parker; Santanu Palchaudhuri; Hanwei Yin; Jianjun Wei; Debabrata Chakravarti
Journal:  Mol Cell Biol       Date:  2012-02-27       Impact factor: 4.272

5.  A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.

Authors:  Ji-Young Kim; Taraswi Banerjee; Aurimas Vinckevicius; Qianyi Luo; J Brandon Parker; Mairead R Baker; Ishwar Radhakrishnan; Jian-Jun Wei; Grant D Barish; Debabrata Chakravarti
Journal:  Mol Cell       Date:  2014-05-01       Impact factor: 17.970

Review 6.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

Review 7.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

8.  Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.

Authors:  Jiri Zavadil; Huihui Ye; Zhaojian Liu; JingJing Wu; Peng Lee; Eva Hernando; Patricia Soteropoulos; Gokce A Toruner; Jian-Jun Wei
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

9.  Growth of uterine leiomyomata among premenopausal black and white women.

Authors:  Shyamal D Peddada; Shannon K Laughlin; Kelly Miner; Jean-Philippe Guyon; Karen Haneke; Heather L Vahdat; Richard C Semelka; Ania Kowalik; Diane Armao; Barbara Davis; Donna Day Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

10.  Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Authors:  Binny V Varghese; Faezeh Koohestani; Michelle McWilliams; Arlene Colvin; Sumedha Gunewardena; William H Kinsey; Romana A Nowak; Warren B Nothnick; Vargheese M Chennathukuzhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.